MS & PHD STUDENTS

Amanda Harrington, PhD

Degree: 
PhD
Program: 
Pharmaceutical Sciences
Track: 
Pharmaceutical Economics, Policy and Outcome
Dissertation Title: 
Evaluation of a Community Pharmacy Pay-for-Preformance Program

Alumna
Year Graduated: 2016
Career Type: Industry
Principal Research Associate for the Global Health Economics and Outcomes Research Department at Allegra

Education
University of Arizona, BS (2008) & MS (2012)

Honors & Achievements
1. Best Podium Award at the Western Pharmacoeconomic Conference, 2012-13.
2. Conference Travel Assistance from the College of Pharmacy Graduate College, 2012-13.
3. Graduate Track Awards: Outstanding Research, 2013-14.
4. Myron Fink Memorial PharmD Scholarship, 2012-13.
5. ISPOR Conference Waiver, 2012-13.
6. ISPOR Distinguished Service Award, for service as Webmaster Committee Chair, 2012-13.
7. ISPOR Outstanding Chapter Award, 2012-13.
8. Katheryn B. Willock Library Research Award, 2012-13.
9. The Arizona Chapter of the Healthcare Information and Management Systems Society (AzHIMSS) Award, 2013-14.
10. Graduate and Professional Student Council Research Grant, 2014-15.

Publications

1. Harrington AR, Warholak TL, Hines L, Taylor A., Sherrill D, Malone, DC. (2011). Healthcare Professional Students’ Knowledge of Drug-Drug Interactions. J Am Pharm Educ, 75(10), 199. PMID: 22345718.
2. Harrington AR, Apgar DA, Hesselbacher E, Pie A, Quesnel A, Desselle SP, Warholak TL. (2012). Pharmacy Students’ Opinions of Direct to Consumer Advertising. Res Social Admin Pharm, available online 18 September 2012.
3. Tang DH, Harrington AR, Lee JK, Armstrong EP (2013). A Systematic Review of Economic Studies on Biologic Agents Used to Treat Crohn’s Disease. Inflamm Bowel Dis, 19(12):2673-2694.
4. Harrington AR, Armstrong EP, Nolan P, Malone DC. (2013). Cost-Effectiveness of Apixaban, Dabigatran, Rivaroxaban, and Warfarin For Stroke Prevention in Atrial Fibrillation. Stroke, 44(6):1676-1681. Epub 2013 Apr 2.
5. Delforge M, Selleslag D, Triffet A, Mineur P, Theunissen K, Graux C, Trullemans F, Boulet D, Van Eygen D, Beguin Y, Noens L, Van Steenweghen S, Lemmens J, Pierre P, D’hondt R, Ferrant A, Deeren D, Van De Velde A, Wynendaele W, André M, De Bock R, Efira A, Breems D, Deweweire A, Geldhof K, Pluymers W, Harrington A, MacDonald K, Abraham I, Ravoet C. (2014). Adequate Iron Chelation Therapy for At least Six Months Improves Survival in Transfusion-Dependent Patients With Lower Risk Myelodysplastic Syndromes. Leuk Res, 38:557-563.

Originally posted: August 29, 2014
Last updated: February 2, 2017
Want to update? Contact Webmaster
Share This